Search Results - "Kemaladewi, Dwi U."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene by Kemaladewi, Dwi U., Bassi, Prabhpreet S., Erwood, Steven, Al-Basha, Dhekra, Gawlik, Kinga I., Lindsay, Kyle, Hyatt, Elzbieta, Kember, Rebekah, Place, Kara M., Marks, Ryan M., Durbeej, Madeleine, Prescott, Steven A., Ivakine, Evgueni A., Cohn, Ronald D.

    Published in Nature (London) (01-08-2019)
    “…Neuromuscular disorders are often caused by heterogeneous mutations in large, structurally complex genes. Targeting compensatory modifier genes could be…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Impaired polyamine metabolism causes behavioral and neuroanatomical defects in a mouse model of Snyder-Robinson Syndrome by Akinyele, Oluwaseun, Munir, Anushe, Johnson, Marie A, Perez, Megan S, Gao, Yuan, Foley, Jackson R, Nwafor, Ashley, Wu, Yijen, Murray-Stewart, Tracy, Casero, Robert A, Bayir, Hulya, Kemaladewi, Dwi U

    Published in Disease models & mechanisms (01-06-2024)
    “…Snyder-Robinson Syndrome (SRS) is a rare X-linked recessive disorder caused by a mutation in the SMS gene encoding spermine synthase and aberrant polyamine…”
    Get full text
    Journal Article
  6. 6
  7. 7

    BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model by Shi, SongTing, Hoogaars, Willem M.H, de Gorter, David J.J, van Heiningen, Sandra H, Lin, Herbert Y, Hong, Charles C, Kemaladewi, Dwi U, Aartsma-Rus, Annemieke, ten Dijke, Peter, t Hoen, Peter A.C

    Published in Neurobiology of disease (01-02-2011)
    “…Abstract Duchenne Muscular Dystrophy (DMD) is an X-linked lethal muscle wasting disease characterized by muscle fiber degeneration and necrosis. The…”
    Get full text
    Journal Article
  8. 8

    Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor by Kemaladewi, Dwi U, Pasteuning, Svitlana, van der Meulen, Joke W, van Heiningen, Sandra H, van Ommen, Gert-Jan, ten Dijke, Peter, Aartsma-Rus, Annemieke, 't Hoen, Peter AC, Hoogaars, Willem M

    Published in Molecular therapy. Nucleic acids (01-04-2014)
    “…Duchenne muscular dystrophy (DMD) is caused by lack of functional dystrophin and results in progressive myofiber damage and degeneration. In addition, impaired…”
    Get full text
    Journal Article
  9. 9

    Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy by Kemaladewi, Dwi U, Hoogaars, Willem M H, van Heiningen, Sandra H, Terlouw, Samuel, de Gorter, David J J, den Dunnen, Johan T, van Ommen, Gert Jan B, Aartsma-Rus, Annemieke, ten Dijke, Peter, 't Hoen, Peter A C

    Published in BMC medical genomics (20-04-2011)
    “…Myostatin is a potent muscle growth inhibitor that belongs to the Transforming Growth Factor-β (TGF-β) family. Mutations leading to non functional myostatin…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Exon Snipping in Duchenne Muscular Dystrophy by Kemaladewi, Dwi U, Cohn, Ronald D

    Published in Trends in molecular medicine (01-03-2016)
    “…Duchenne muscular dystrophy (DMD) is a life-limiting neuromuscular disorder caused by mutations in the DMD gene encoding dystrophin. We discuss very recent…”
    Get full text
    Journal Article
  13. 13

    Cell‐type specific regulation of myostatin signaling by Kemaladewi, Dwi U., Gorter, David J. J., Aartsma‐Rus, Annemieke, Ommen, Gert‐Jan, Dijke, Peter ten, Hoen, Peter A. C. 't, Hoogaars, Willem M.

    Published in The FASEB journal (01-04-2012)
    “…The transforming growth factor (TGF)‐β family member myostatin is an important regulator of myoblast, adipocyte, and fibroblast growth and differentiation, but…”
    Get full text
    Journal Article
  14. 14

    Early-career researchers in the time of COVID-19: Benefits of structural support

    Published in Cell stem cell (06-05-2021)
    “…COVID-19 shutdowns have had detrimental impacts on new labs, but thoughtful support from institutions and funding bodies may alleviate key pressures and…”
    Get full text
    Journal Article
  15. 15

    Introductions to the Community: Early-Career Researchers in the Time of COVID-19

    Published in Cell stem cell (04-06-2020)
    “…COVID-19 has unfortunately halted lab work, conferences, and in-person networking, which is especially detrimental to researchers just starting their labs…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva. e69096 by Shi, SongTing, Cai, Jie, Gorter, J Jde, Sanchez-Duffhues, Gonzalo, Kemaladewi, Dwi U, Hoogaars, Willem MH, Aartsma-Rus, Annemieke, Hoen, A C't, Dijke, Peter ten

    Published in PloS one (01-07-2013)
    “…Fibrodysplasia ossificans progressiva (FOP) is a rare heritable disease characterized by progressive heterotopic ossification of connective tissues, for which…”
    Get full text
    Journal Article
  18. 18

    Targeting TGF-[beta] Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-[beta] Type I Receptor by Kemaladewi, Dwi U, Pasteuning, Svitlana, Van Der Meulen, Joke W, Van Heiningen, Sandra H, Van Ommen, Gert-jan, Ten Dijke, Peter, Aartsma-rus, Annemieke, 't Hoen, Peter Ac, Hoogaars, Willem M

    Published in Molecular therapy. Nucleic acids (01-04-2014)
    “…Duchenne muscular dystrophy (DMD) is caused by lack of functional dystrophin and results in progressive myofiber damage and degeneration. In addition, impaired…”
    Get full text
    Journal Article
  19. 19